UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME
Sales, net	$ 12,520	$ 12,323
Cost of goods sold	4,677	4,790
Gross profit	7,843	7,533
Operating expense
Selling, general and administrative	3,260	2,888
Research & development	144	123
Total operating expenses	3,404	3,011
Operating income	4,439	4,522
Other income	680	8
Income before provision for income taxes	5,119	4,530
Provision for income taxes	905	996
Net income	$ 4,214	$ 3,534
Earnings per common share (basic)	$ 1.16	$ 0.97
Earnings per common share (diluted)	$ 1.16	$ 0.96
Shares outstanding (basic)	3,628	3,655
Shares outstanding (diluted)	3,636	3,665
Other comprehensive income (loss)
Foreign currency translation net of taxes of $0 in all periods	$ 549	$ (506)
Total comprehensive income	$ 4,763	$ 3,028